43. Hu C, Tkebuchava T. Health in All Laws: a better strategy for global health. J Evidence-Based Med 2022;15:10-4.
44. Rayes JBrill A. Hot under the clot: venous thrombogenesis is an inflammatory process. Blood 2024;144:477-89.
45. Verma D, Kumar R, Pereira RS, et al. Vitamin K antagonism impairs the bone marrow microenvironment and hematopoiesis. Blood 2019;134:227-38.
46. Caiado F , Kovtonyuk LV, Gonullu NG, Fullin J, Boettcher S, Manz MG. Aging drives Tet2+/- clonal hematopoiesis via IL-1 signaling. Blood 2023;141:886-903.
47. Caiado FManz MG. IL-1 in aging and pathologies of hematopoietic stem cells. Blood 2024;144:368-77.
48. Hu, C. Emergency Protective Measures and Strategies of COVID-19: From Lifestyle to Traditional Chinese Medicine. Clin Complement Med Pharmacol 2023;3:100089.
49. Hu C, Tkebuchava T, Wu Q. A Novel Comprehensive Program Combining Optimal Medical Treatment with Lifestyle Modification for Type 2 Diabetes. Cardiovasc Sci 2024;1:10004. https://doi.org/10.35534/cvs.2024.10004
50. Bunne C, Roohani Y, Rosen Y, Gupta A, Zhang X, Roed M, Alexandrov T, AlQuraishi M, Brennan P, Burkhardt DB, Califano A, Cool J, Dernburg AF, Ewing K, Fox EB, Haury M, Herr AE, Horvitz E, Hsu PD, Jain V, Johnson GR, Kalil T, Kelley DR, Kelley SO, Kreshuk A, Mitchison T, Otte S, Shendure J, Sofroniew NJ, Theis F, Theodoris CV, Upadhyayula S, Valer M, Wang B, Xing E, Yeung-Levy S, Zitnik M, Karaletsos T, Regev A, Lundberg E, Leskovec J, Quake SR. How to build the virtual cell with artificial intelligence: Priorities and opportunities. Cell 2024;187(25):7045-7063.
Table 1. The “magic polypill” or E(e)SEEDi as a “super-vaccine” and a “super-therapy” for human diseases.